Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Group Psychotherapy for People With HIV [NA]
A completed clinical trial evaluating group psychotherapy for people with HIV, focusing on comorbid depression.
-
CLINICAL_TRIALS trial_result · 2013-11-28Clinical Trial Update: A Letter Intervention in Primary Care Patients to Improve Depression and Anxiety Disorders [Phase 1]
Phase 1 clinical trial evaluating a letter-based intervention in primary care to improve depression and anxiety; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder [Phase 3]
Phase 3 study evaluating adjunctive aripiprazole added to antidepressant therapy for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder [Phase 3]
The document reports completion of a Phase 3 trial evaluating adjunctive aripiprazole for major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: Prevalence and Effect of Detecting Common Mental Disorders in Long-term Sickness Absence [NA]
A completed clinical trial update examining the prevalence of common mental disorders in individuals with long-term sickness absence and the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder [Phase 2]
Phase 2 trial results evaluating the safety and efficacy of RX-10100 for Major Depressive Disorder.
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD) [Phase 2]
A Phase 2 efficacy study of RX-10100 for major depressive disorder has completed, according to Rexahn Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Treatment of Reduced Heart Rate Variability Associated With Major Depression With Electroconvulsive Therapy
A completed clinical trial from Emory University evaluated electroconvulsive therapy for reduced heart rate variability in patients with maj…
-
CLINICAL_TRIALS trial_result · 2013-11-18Clinical Trial Update: E-health Cognitive Behavioral Therapy in Women Treated by in Vitro Fertilization (IVF) [NA]
Clinical trial update on an online/e-health cognitive behavioral therapy program for women undergoing IVF to address depression and anxiety.
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy [Phase 2]
Phase 2 clinical trial testing whether antidepressant medication combined with directly observed therapy improves adherence to antiretrovira…
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Cimicoxib for the Treatment of Major Depression (SECIM) [Phase 2]
Phase 2 trial of Cimicoxib for major depression has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Characterizing Psychological Consequences of Childhood Trauma
A completed clinical trial by Emory University studying the psychological consequences of childhood trauma in individuals with Major Depress…
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood? [NA]
A completed Emory University clinical trial evaluated whether fluoxetine affects CNS CRF systems in women with a history of childhood abuse,…
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue. [Phase 4]
Phase 4 trial evaluating adding modafinil (Provigil) to SSRI therapy for adults with mild-to-moderate major depressive disorder experiencing…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Disorder
A completed clinical trial evaluated the impact of atypical antipsychotic therapy on health outcomes and costs for patients with major depre…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder [Phase 3]
This document summarizes the completion of a long-term Phase 3 study evaluating aripiprazole for major depressive disorder. The trial is spo…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: The Effect of Patient Cost-Sharing on Antidepressant and Adjunctive Therapy Use
A completed clinical trial evaluating how patient cost-sharing affects antidepressant and adjunctive therapy use.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Cognitive Behavioral Therapy for Depression Relapse Prevention in Children and Adolescents [NA]
This document reports a completed clinical trial evaluating cognitive behavioral therapy to prevent relapse of depression in children and ad…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Outcomes in MEasurement-Based Treatment
The document reports outcomes from a completed clinical trial (NCT01141387) studying measurement-based treatment for major depressive disord…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder [Phase 2, Phase 3]
This clinical trial update concerns a sustained-release formulation of desvenlafaxine hydrochloride for the treatment of major depressive di…
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder [Phase 3]
Long-term extension results from a Phase 3 study of vortioxetine (Lu AA21004) in adults with major depressive disorder, focusing on safety a…
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD [Phase 3]
Phase 3 trial evaluated three doses of DVS SR in outpatients with major depressive disorder using paroxetine as a reference drug. The study …
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: Comparison of Measures of Plasticity [NA]
A completed clinical trial comparing measures of plasticity in individuals with major depressive disorder and healthy controls.
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: Treatment Choices for Improving Adherence and Outcome [NA]
This clinical trial update discusses treatment choices aimed at improving adherence and outcomes for major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder [Phase 3]
Phase 3 results assess safety and efficacy of Levomilnacipran ER in adults with Major Depressive Disorder; the study results were posted in …